Fundz

Electra Therapeutics Announces $84 Million Series B Financing And Unveils Its Novel Sirp‑Targeted Therapies For Immunological Diseases And Cancer

PUBLIC · ETRAFeb 16, 2022

Amount Raised

$84 Million

Round Type

Series B

South San FranciscoManufacturingBiotechnologySustainabilityHealth CareScience And EngineeringMining

Description

Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies that target signal regulatory proteins (SIRP), announced today a $84 million Series B financing co-led by Westlake Village BioPartners and OrbiMed. Other participating investors include Redmile Group, Cormorant Asset Management, Cowen Healthcare Investments, RA Capital, and New Leaf Venture Partners. Electra was previously funded by its parent company, Star Therapeutics.

Who else raised in Sustainability and Science And Engineering around the same time

Companies in the same sectors as Electra Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Advanced NanoTherapies raised $9.2M on January 26, 2022.
  • Co-Diagnostics, Inc. raised $47M on January 14, 2022.
  • 2seventy bio raised $170M on March 31, 2022.
  • Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
  • Geneos Therapeutics raised $17M on March 28, 2022.
  • Geneos Therapeutics raised $17M (Series A) on March 24, 2022.

Who to call at Electra Therapeutics, and when

A new round usually means Electra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Electra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Electra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Electra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Electra Therapeutics

Location

230 East Grand Avenue, Suite S-100

South San Francisco, California, United States

About

Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Electra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Electra Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Electra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.